Fennec Pharmaceuticals (FENC) vs TRex Bio (TRXB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
TRex Bio is the larger company by market cap ($385.1 million vs $375.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | FENC | TRXB |
|---|---|---|
| Share price | $10.72 | $14.03 |
| Market cap | $375.92M | $385.06M |
| 1-day change | +0.09% | +0.21% |
| YTD return | +39.09% | — |
| 1-year return | +26.90% | — |
| 5-year return | +16.54% | — |
| Forward P/E | 11.31 | — |
| EPS (TTM) | $-0.12 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $44.64M | — |
| Revenue growth (YoY) | -6.09% | — |
| Net income (latest FY) | $-9.74M | — |
| Operating margin | -14.07% | — |
| Net margin | -21.82% | — |
| 52-week high | $13.25 | $15.50 |
| 52-week low | $5.65 | $13.50 |
| Distance from 52-week high | -19.09% | -9.48% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +64.83% | — |
| Average volume | 191.88K | 1.26M |
| Shares outstanding | 35.07M | 27.45M |
| Employees | 35 | 60 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Fennec Pharmaceuticals
FENC stock →Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 35 employees
About TRex Bio
TRXB stock →TRex Bio, Inc. operates as a clinical-stage biopharmaceutical company that engages in discovery and development of immunoregulatory medicines.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
FENC vs TRXB FAQ
Which is bigger, Fennec Pharmaceuticals or TRex Bio?
TRex Bio (TRXB) is larger, with a market capitalization of $385.06M compared with $375.92M for Fennec Pharmaceuticals (FENC).
Are Fennec Pharmaceuticals and TRex Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.